… eligible-ASCT)YesGO29365:Multicentre/open-label/phase Ib/II vs.Rituximab/bendamustine2A (OS improvement)Improved mPFS by 5.8 mo(HR=0.36)…
5articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Bendamustine ×
Bendamustine
This drug is selected. Its supporting articles are shown below.
Articles mentioning Bendamustine
5 articles · page 1 of 1RituximabBendamustineSecondPolatuzumab-R-CHPbendamustine2ALenalidomideSecondBendamustinePolatuzumab-Rhaematologic malignanciesDLBCLMinistry of Health
rituximabpolatuzumabbendamustineB-cell lymphomamarginal zone lymphomaC3 crescentic GNFLBCLdialysis
…sis. The patient was treated with polatuzumab, bendamustine and rituximab, which was well tolerated. Renal function gradually improved, l…
bendamustinefludarabine/cyclophosphamidevenetoclaxtocilizumabCD4CARIndiana UniversityFDAAMLacute myeloid leukemiaschronic myelomonocytic leukemia+2 more
…eived conditioning with either fludarabine/cyclophosphamide, or bendamustine, followed by CD4CAR in a 3+3 dose-escalation design. Safety and…
bendamustinerituximabCLLchronic lymphocytic leukaemia
…ion, 11q deletion or t (11;14). He then received four cycles of bendamustine and rituximab, and at the end of the treatment complete blood c…
98.0%
rituximabbendamustinechronic lymphocytic leukaemiaend-stage renal diseaseBMJ Case Rep.CLLESRD
…Shoji J, Lew SQ. The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL…